RHUMBLINE ADVISERS - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 60 filers reported holding MARKER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$57,000
+54.1%
25,308
+0.4%
0.00%
Q4 2020$37,000
+12.1%
25,208
+15.3%
0.00%
Q3 2020$33,000
-47.6%
21,866
-28.7%
0.00%
Q2 2020$63,000
+50.0%
30,651
+38.5%
0.00%
Q1 2020$42,000
-34.4%
22,1260.0%0.00%
Q4 2019$64,000
-42.3%
22,126
+1.8%
0.00%
Q3 2019$111,000
-32.3%
21,739
+5.1%
0.00%
Q2 2019$164,00020,6800.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders